Cargando…

Targeting the Cholinergic System to Develop a Novel Therapy for Huntington’s Disease

In this review, we outline the role of the cholinergic system in Huntington’s disease, and briefly describe the dysfunction of cholinergic transmission, cholinergic neurons, cholinergic receptors and cholinergic survival factors observed in post-mortem human brains and animal models of Huntington’s...

Descripción completa

Detalles Bibliográficos
Autores principales:	D’Souza, Gary X., Waldvogel, Henry J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5181681/ https://www.ncbi.nlm.nih.gov/pubmed/27983560 http://dx.doi.org/10.3233/JHD-160200

Ejemplares similares

Effect of Estradiol on Neurotrophin Receptors in Basal Forebrain Cholinergic Neurons: Relevance for Alzheimer’s Disease
por: Kwakowsky, Andrea, et al.
Publicado: (2016)

Current and Possible Future Therapeutic Options for Huntington’s Disease
por: Ferguson, Mackenzie W., et al.
Publicado: (2022)

The Role of Microglia and Astrocytes in Huntington’s Disease
por: Palpagama, Thulani H., et al.
Publicado: (2019)

Targeting the cholinergic system in Parkinson’s disease
por: Liu, Changliang
Publicado: (2020)

Novel targets for Huntington’s disease: future prospects
por: Mason, Sarah L, et al.
Publicado: (2016)

Purine Nucleotides Metabolism and Signaling in Huntington’s Disease: Search for a Target for Novel Therapies
por: Tomczyk, Marta, et al.
Publicado: (2021)

Cholinergic Interneurons Amplify Corticostriatal Synaptic Responses in the Q175 Model of Huntington’s Disease
por: Tanimura, Asami, et al.
Publicado: (2016)

Alzheimer's Disease: Targeting the Cholinergic System
por: Ferreira-Vieira, Talita H., et al.
Publicado: (2016)

Enhanced GABAergic Inhibition of Cholinergic Interneurons in the zQ175(+/−) Mouse Model of Huntington's Disease
por: Lim, Sean Austin O., et al.
Publicado: (2021)

Paying attention to smell: cholinergic signaling in the olfactory bulb
por: D’Souza, Rinaldo D., et al.
Publicado: (2014)

A Novel Therapy for Huntington’s Disease
por: La Spada, Albert R.
Publicado: (2018)

Thalamostriatal degeneration contributes to dystonia and cholinergic interneuron dysfunction in a mouse model of Huntington’s disease
por: Crevier-Sorbo, Gabriel, et al.
Publicado: (2020)

Cerebellar degeneration correlates with motor symptoms in Huntington disease
por: Singh‐Bains, Malvindar K., et al.
Publicado: (2019)

Cholinergic deficits selectively boost cortical intratelencephalic control of striatum in male Huntington’s disease model mice
por: Pancani, Tristano, et al.
Publicado: (2023)

Prion‐like mechanisms in neurodegenerative disease: Implications for Huntington's disease therapy
por: Srinageshwar, Bhairavi, et al.
Publicado: (2020)

The Cholinergic System, the Adrenergic System and the Neuropathology of Alzheimer’s Disease
por: Bekdash, Rola A.
Publicado: (2021)

Cholinergic Modulation of the Immune System in Neuroinflammatory Diseases
por: Reale, Marcella, et al.
Publicado: (2021)

Targeting Huntington’s disease through histone deacetylases
por: Gray, Steven G.
Publicado: (2011)

The epithelial cholinergic system of the airways
por: Kummer, W., et al.
Publicado: (2008)

Striatal parvalbuminergic neurons are lost in Huntington's disease: implications for dystonia
por: Reiner, Anton, et al.
Publicado: (2013)

No symphony without bassoon and piccolo: changes in synaptic active zone proteins in Huntington’s disease
por: Huang, Ting-Ting, et al.
Publicado: (2020)

Alzheimer’s Disease Pharmacotherapy in Relation to Cholinergic System Involvement
por: Stanciu, Gabriela Dumitrita, et al.
Publicado: (2019)

Novel circuitry and molecular pathogenic mechanisms in Huntington's disease
por: Yang, X William
Publicado: (2012)

The Role of the Immune System in Huntington's Disease
por: Ellrichmann, Gisa, et al.
Publicado: (2013)

Revisiting the neuropsychiatry of Huntington's disease
por: Teixeira, Antonio Lucio, et al.
Publicado: (2016)

Pharmacological and Electroceutical Targeting of the Cholinergic Anti-Inflammatory Pathway in Autoimmune Diseases
por: Zouali, Moncef
Publicado: (2023)

The updated development of blood-based biomarkers for Huntington’s disease
por: Zhang, Sirui, et al.
Publicado: (2023)

Targeting the non-neuronal cholinergic system in macrophages for the management of infectious diseases and cancer: challenge and promise
por: Reichrath, Sandra, et al.
Publicado: (2016)

Irritability in Huntington’s Disease
por: Karagas, Nicholas E., et al.
Publicado: (2020)

Targeting the proteostasis network in Huntington’s disease
por: Soares, Tânia R., et al.
Publicado: (2019)

Neurodegenerative processes in Huntington's disease
por: Bano, D, et al.
Publicado: (2011)

Glycation in Huntington’s Disease: A Possible Modifier and Target for Intervention
por: Brás, Inês Caldeira, et al.
Publicado: (2019)

The ubiquitin proteasome system in Huntington's disease and the spinocerebellar ataxias
por: Davies, Janet E, et al.
Publicado: (2007)

Huntington's disease accelerates epigenetic aging of human brain and disrupts DNA methylation levels
por: Horvath, Steve, et al.
Publicado: (2016)

Nucleic Acid-Based Therapy Approaches for Huntington's Disease
por: Vagner, Tatyana, et al.
Publicado: (2012)

The P42 peptide and Peptide-based therapies for Huntington’s disease
por: Marelli, Cecilia, et al.
Publicado: (2016)

Structural connections between the noradrenergic and cholinergic system shape the dynamics of functional brain networks
por: Taylor, N.L., et al.
Publicado: (2022)

Transgenic animal models for study of the pathogenesis of Huntington’s disease and therapy
por: Chang, Renbao, et al.
Publicado: (2015)

Alzheimer's disease, anesthesia and the cholinergic system
por: Kapoor, Mukul C
Publicado: (2011)

Huntington’s Disease Drug Development: A Phase 3 Pipeline Analysis
por: Van de Roovaart, Hannah J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8orh768n68mjhsk0b8cet9sge2